US Stock MarketDetailed Quotes

AYTU Aytu BioPharma

Watchlist
  • 1.5082
  • +0.0182+1.22%
Close Nov 21 16:00 ET
9.27MMarket Cap-985P/E (TTM)

Aytu BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aytu BioPharma Q1 2025 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
13.77M
16.57M
+2.81M
Beat Est.
-37.70%
-6.98%
+20.38%
EPS
-0.34
-0.15
+0.19
Beat Est.
+77.03%
+89.86%
+55.87%
Analyst Rating
Buy

Jul 31, 2024

Aytu BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 17.587M--
--2025/Q2-- / 15.554M--
Nov 13, 20242025/Q116.574M / 13.768M--
Sep 26, 20242024/Q417.976M / 18.301M--
May 15, 20242024/Q317.993M / 17.346M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 17.587M--
--2025/Q2-- / 15.554M--
Nov 13, 20242025/Q116.574M / 13.768M--
Sep 26, 20242024/Q417.976M / 18.301M--
May 15, 20242024/Q317.993M / 17.346M--

Unlock Free Earnings Estimates

Aytu BioPharma Earnings Reports

  • Aytu BioPharma | 10-Q: Q1 2025 Earnings Report

    Nov 13 17:23 ET

  • Aytu BioPharma | 8-K: Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

    Nov 13 16:30 ET

  • Aytu BioPharma | 8-K: Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

    Sep 26 16:37 ET

  • Aytu BioPharma | 10-K: FY2024 Annual Report

    Sep 26 16:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data